Report cover image

North America Contraceptive Drugs Market by Product Type, End-Use, and Country-wise Insights: Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2025 - 2032

Publisher Persistence Research & Consultancy Services
Published Jul 09, 2025
Length 188 Pages
SKU # PERR20198821

Description

Persistence Market Research has recently released a comprehensive report on the North America contraceptive drugs market. The report offers a thorough assessment of crucial market dynamics, including drivers, trends, opportunities, and challenges, providing detailed insights into the market structure. This research publication presents exclusive data and statistics outlining the anticipated growth trajectory of the North America contraceptive drugs market from 2025 to 2032.

Key Insights:
  • North America Contraceptive Drugs Market Size (2025E): USD 2.67 Billion
  • Projected Market Value (2032F): USD 4.79 Billion
  • Regional Market Growth Rate (CAGR 2025 to 2032): 5.7%
North America Contraceptive Drugs Market - Report Scope:

Contraceptive drugs play a crucial role in family planning and reproductive health by providing effective methods to prevent unintended pregnancies. These drugs include hormonal contraceptives such as oral pills, injectables, implants, patches, and vaginal rings, as well as non-hormonal options like spermicides and barrier contraceptives. The market caters to a wide range of end-users including hospitals, clinics, family planning centers, and pharmacies. Growth in this market is driven by increasing awareness regarding family planning, rising healthcare expenditure, growing female workforce participation, and advancements in contraceptive drug formulations that enhance efficacy and reduce side effects.

Market Growth Drivers:

The North America contraceptive drugs market is propelled by several key factors, including the increasing demand for reliable and convenient contraception methods among women of reproductive age. Growing public health initiatives promoting safe sex practices and family planning further stimulate market expansion. Technological advancements in drug delivery systems, such as extended-release contraceptives and non-oral options, provide improved compliance and user experience. Moreover, the rising prevalence of sexually transmitted infections (STIs) and the need for dual protection methods boost the adoption of contraceptive drugs. Additionally, expanding access to contraceptives through government programs and insurance coverage supports market growth.

Market Restraints:

Despite promising growth prospects, the market faces challenges such as regulatory hurdles related to drug approvals and safety concerns associated with hormonal contraceptives. Side effects and health risks reported by some users may impact adoption rates. Additionally, social and cultural stigma around contraception and varying reimbursement policies across regions may restrict market penetration. Addressing these barriers requires continued education, improved drug safety profiles, and supportive healthcare policies.

Market Opportunities:

The North America contraceptive drugs market presents significant opportunities driven by ongoing research and development efforts aimed at creating novel contraceptive options with fewer side effects and longer durations of action. Increasing demand for male contraceptives and non-hormonal alternatives offers new avenues for innovation. Furthermore, digital health platforms facilitating telemedicine consultations and online prescription services enhance access and convenience for users. Strategic partnerships between pharmaceutical companies and healthcare providers, along with targeted awareness campaigns, can help capture emerging opportunities and expand market reach.

Key Questions Answered in the Report:
  • What are the primary factors driving the growth of the contraceptive drugs market in North America?
  • Which drug types and contraceptive methods are most preferred by consumers and healthcare providers?
  • How are technological advancements reshaping the competitive landscape of the contraceptive drugs market?
  • Who are the key players contributing to the North America contraceptive drugs market, and what strategies are they employing to maintain market relevance?
  • What are the emerging trends and future prospects in the regional contraceptive drugs market?
Competitive Intelligence and Business Strategy:

These companies invest heavily in R&D to develop advanced contraceptive formulations with improved safety profiles and ease of use. Collaborations with healthcare organizations and digital health platforms facilitate market access and consumer engagement. Additionally, emphasis on clinical research, patient education, and expanded distribution networks supports sustained market growth and enhances patient outcomes.

Key Companies Profiled:
  • Church & Dwight Co., Inc.
  • Reckitt Benckiser Group Plc
  • Veru, Inc.
  • Organon Group of Companies
  • Pfizer, Inc.
  • Teva Pharmaceutical Industries Ltd.
  • The Cooper Companies, Inc.
  • Mayer Laboratories, Inc.
  • Agile Therapeutics
  • TherapeuticsmMD, Inc.
  • Bayer Ag
  • Afaxys, Inc.
  • Mithra Pharmaceuticals
  • Abbvie
North America Contraceptive Drugs Market Research Segmentation:

The contraceptive drugs market in North America encompasses a diverse range of products, formulations, applications, and end-user segments, addressing various consumer needs and preferences.

By Type
  • Oral Contraceptives
  • Injectable
  • Implants
By Distribution Channel
  • Retail Pharmacies
  • Online Pharmacies
  • Hospitals & Clinics
By Country
  • U.S.
  • Canada


Please Note: It will take 5 business days to complete the report upon order confirmation.

Table of Contents

188 Pages
1. Executive Summary
1.1. North America Contraceptive Drugs Market Snapshot, 2025 and 2032
1.2. Market Opportunity Assessment, 2025-2032, US$ Bn
1.3. Key Market Trends
1.4. Future Market Projections
1.5. Premium Market Insights
1.6. Industry Developments and Key Market Events
1.7. PMR Analysis and Recommendations
2. Market Overview
2.1. Market Scope and Definition
2.2. Market Dynamics
2.2.1. Drivers
2.2.2. Restraints
2.2.3. Opportunity
2.2.4. Challenges
2.2.5. Key Trends
2.3. COVID-19 Impact Analysis
2.4. Forecast Factors – Relevance and Impact
3. Value Added Insights
3.1. Value Chain Analysis
3.2. Technology Assessment
3.3. Type Adoption / Usage Analysis
3.4. Key Market Players
3.5. Regulatory Landscape
3.6. PESTLE Analysis
3.7. Porter’s Five Force Analysis
4. North America Contraceptive Drugs Market Outlook
4.1. Key Highlights
4.1.1. Market Size (US$ Bn) and Y-o-Y Growth
4.1.2. Absolute $ Opportunity
4.2. Market Size (US$ Bn) Analysis and Forecast
4.2.1. Historical Market Size (US$ Bn) Analysis, 2019-2024
4.2.2. Current Market Size (US$ Bn) Analysis and Forecast, 2025–2032
4.3. North America Contraceptive Drugs Market Outlook: Type
4.3.1. Historical Market Size (US$ Bn) Analysis, By Type, 2019-2024
4.3.2. Current Market Size (US$ Bn) and Forecast Analysis, By Type, 2025–2032
4.3.2.1. Oral Contraceptives
4.3.2.2. Injectable
4.3.2.3. Implants
4.3.3. Market Attractiveness Analysis: Type
4.4. North America Contraceptive Drugs Market Outlook: Distribution Channel
4.4.1. Historical Market Size (US$ Bn) Analysis, By Distribution Channel, 2019-2024
4.4.2. Current Market Size (US$ Bn) Analysis and Forecast, By Distribution Channel, 2025–2032
4.4.2.1. Retail Pharmacies
4.4.2.2. Online Pharmacies
4.4.2.3. Hospitals & Clinics
4.4.3. Market Attractiveness Analysis: Distribution Channel
5. North America Contraceptive Drugs Market Outlook: Country
5.1. Historical Market Size (US$ Bn) Analysis, By Country, 2019-2024
5.2. Current Market Size (US$ Bn) and Forecast Analysis, By Country, 2025–2032
5.2.1. U.S.
5.2.2. Canada
5.3. Market Attractiveness Analysis: Country
6. U.S. Contraceptive Drugs Market Outlook
6.1. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2024
6.1.1. By Type
6.1.2. By Distribution Channel
6.2. Current Market Size (US$ Bn) and Forecast Analysis, By Type, 2025–2032
6.2.1. Oral Contraceptives
6.2.2. Injectable
6.2.3. Implants
6.3. Current Market Size (US$ Bn) Analysis and Forecast, By Distribution Channel, 2025–2032
6.3.1. Retail Pharmacies
6.3.2. Online Pharmacies
6.3.3. Hospitals & Clinics
6.4. Market Attractiveness Analysis
7. Canada Contraceptive Drugs Market Outlook
7.1. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2024
7.1.1. By Type
7.1.2. By Distribution Channel
7.2. Current Market Size (US$ Bn) and Forecast Analysis, By Type, 2025–2032
7.2.1. Oral Contraceptives
7.2.2. Injectable
7.2.3. Implants
7.3. Current Market Size (US$ Bn) Analysis and Forecast, By Distribution Channel, 2025–2032
7.3.1. Retail Pharmacies
7.3.2. Online Pharmacies
7.3.3. Hospitals & Clinics
7.4. Market Attractiveness Analysis
8. Competition Landscape
8.1. Market Share Analysis, 2025
8.2. Market Structure
8.2.1. Competition Intensity Mapping by Market
8.2.2. Competition Dashboard
8.3. Company Profiles (Details – Overview, Financials, Strategy, Recent Developments)
8.3.1. Church & Dwight Co., Inc.
8.3.1.1. Overview
8.3.1.2. Segments and Sources
8.3.1.3. Key Financials
8.3.1.4. Market Developments
8.3.1.5. Market Strategy
8.3.2. Reckitt Benckiser Group Plc
8.3.3. Veru, Inc.
8.3.4. Organon Group of Companies
8.3.5. Pfizer, Inc.
8.3.6. Teva Pharmaceutical Industries Ltd.
8.3.7. The Cooper Companies, Inc.
8.3.8. Mayer Laboratories, Inc.
8.3.9. Agile Therapeutics
8.3.10. TherapeuticsmMD, Inc.
8.3.11. Bayer Ag
8.3.12. Afaxys, Inc.
8.3.13. Mithra Pharmaceuticals
8.3.14. Abbvie
8.3.15. Others
9. Appendix
9.1. Research Methodology
9.2. Research Assumptions
9.3. Acronyms and Abbreviations

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us